Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love

Boston Scientific trades around $61, while analyst price targets span $69 to $124, implying meaningful upside from current levels. The note is constructive but limited to valuation commentary rather than new operational results or guidance. The wide target range suggests positive analyst sentiment, though with notable dispersion in expectations.

Analysis

Boston Scientific trades around $61, while analyst price targets span $69 to $124, implying meaningful upside from current levels. The note is constructive but limited to valuation commentary rather than new operational results or guidance. The wide target range suggests positive analyst sentiment, though with notable dispersion in expectations.